StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) shareholders

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.41−0.29 (-3.77%)

Close on Nov 17, 2026Market cap $671.08MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
99M of 91M shares
Institutional holders
158
34 new, 28 sold out
Net institutional buying
17M
In Q2 2026
Insider trades, 12 months
0 buys · 32 sales
Net sold $1.07M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
RTW Investments, LP
Joint filing with Roderick Wong (9.90%)
9,018,7249.90%13G (passive) amendmentMar 31, 2026
Roderick Wong
Joint filing with RTW Investments, LP (9.90%)
7,836,3469.90%13G (passive) amendmentDec 31, 2025
Deep Track Capital, LP
Joint filing with Deep Track Biotechnology Master Fund, Ltd. (9.99%), David Kroin (9.99%)
7,719,3909.99%13G (passive)Nov 14, 2025
Armistice Capital, LLC
Joint filing with Steven Boyd (7.76%)
7,024,0007.76%13G (passive) amendmentJun 30, 2026
BlackRock, Inc.6,187,0127.00%13G (passive) amendmentJun 30, 2026
Bam Gp LLC
Joint filing with Balyasny Asset Management L.P. (9.99%), Balyasny Asset Management Holdings LP (9.99%) and 2 more
5,777,3969.99%13G (passive) amendmentJun 30, 2025
Lampert Mark N
Joint filing with Bvf Partners L P/Il (9.99%), Bvf Inc/Il (9.99%) and 3 more
5,720,8319.99%13G (passive) amendmentJun 30, 2025
Dames GP LLC
Joint filing with Balyasny Asset Management L.P. (9.29%), Bam Gp LLC (9.29%) and 2 more
5,718,1909.29%13G (passive) amendmentSep 30, 2025
Daniel Mack
Joint filing with Nantahala Capital Management, LLC (9.99%), Wilmot B. Harkey (9.99%)
5,459,2789.99%13G (passive) amendmentMar 31, 2025
Bvf Partners L P/Il
Joint filing with Bvf Inc/Il (9.99%), Lampert Mark N (9.99%) and 3 more
4,706,5519.99%13G (passive) amendmentDec 31, 2024
Wilmot B. Harkey
Joint filing with Nantahala Capital Management, LLC (7.13%), Daniel Mack (7.13%)
4,626,2367.13%13G (passive) amendmentSep 30, 2025
Roderick Wong, M.D.
Joint filing with RTW Investments, LP (8.30%)
4,245,4768.30%13G (passive)Mar 31, 2025
Ramya Rao3,949,8018.87%13G (passive)Dec 31, 2024
Steven Boyd
Joint filing with Armistice Capital, LLC (5.30%)
3,536,0005.30%13G (passive)Dec 31, 2025
Logos GP LLC
Joint filing with Logos Global Management LP (6.20%), Logos Global Management GP LLC (6.20%) and 2 more
3,425,0006.20%13G (passive)Jul 21, 2025
Polar Capital Funds PLC - Biotechnology Fund
Joint filing with Polar Capital Holdings Plc (5.09%), Polar Capital LLP (5.09%)
3,398,8995.09%13G (passive)Dec 31, 2025
Soleus GP LLC
Joint filing with Soleus Capital Management, L.P. (7.30%), Guy Levy (7.30%)
3,350,6927.30%13G (passive) amendmentDec 31, 2024
Tananbaum James B.
Joint filing with Foresite Capital Fund VI LP (5.10%), Foresite Capital Management VI, LLC (5.10%)
3,135,1205.10%13G (passive)Oct 16, 2025
Stonepine Capital Management, LLC
Joint filing with Stonepine Capital, L.P. (5.00%), Stonepine GP, LLC (5.00%) and 1 more
2,833,3335.00%13G (passive)Jul 22, 2025
Vivo Opportunity Fund Holdings, L.P.
Joint filing with Vivo Opportunity, LLC (6.10%)
1,538,4616.10%13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of VSTMValueChange% of portfolio
BlackRock, Inc.9,192,44710.15%$35.12M+2,997,5220.00%
Nantahala Capital Management, LLC7,169,6407.92%$27.39M+3,584,8200.46%
Armistice Capital, LLC7,024,0007.76%$26.83M+2,432,0000.33%
Rtw Investments, LP6,635,7937.33%$25.35M+59,4870.22%
Deep Track Capital, LP5,740,8506.34%$21.93M–0.32%
State Street Corp5,133,8595.67%$19.61M+1,617,2080.00%
Rosalind Advisors, Inc.3,986,5094.40%$15.23M+1,848,0345.66%
Vanguard Capital Management LLC3,851,5084.25%$14.71M+528,7380.00%
Stonepine Capital Management, LLC3,349,6273.70%$12.80M+47,3277.22%
Vanguard Portfolio Management LLC3,266,8703.61%$12.48M+2,509,9950.00%
Foresite Capital Management VI LLC3,146,6313.47%$12.02M–1.87%
Goldman Sachs Group Inc2,721,1783.00%$10.39M+1,237,1750.00%
Baker Bros. Advisors LP2,499,3382.76%$9.55M+1,914,5810.05%
Alyeska Investment Group, L.P.2,289,6252.53%$8.75M+239,6250.02%
Millennium Management LLC2,078,0032.29%$7.94M−333,9620.00%
Geode Capital Management, LLC2,074,1452.29%$7.93M+356,5880.00%
AIGH Capital Management LLC1,927,0002.13%$7.36M−73,0000.46%
Opaleye Management Inc.1,800,0001.99%$6.88MNew0.62%
Balyasny Asset Management L.P.1,686,5751.86%$6.44M+1,276,7960.01%
Qube Research & Technologies Ltd1,628,4881.80%$6.22M+152,4600.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202615899M100.0%34 / 6937 / 2829M11M
Q1 202615581M89.9%41 / 7026 / 2726M17M
Q4 202514377M84.5%45 / 5031 / 2032M15M
Q3 202511860M65.9%29 / 4036 / 1922M15M
Q2 202510953M58.5%28 / 4621 / 1720M10M
Q1 20259943M47.8%21 / 3624 / 1214M5M
Q4 20249235M38.3%29 / 3711 / 1414M6M
Q3 20247727M29.4%21 / 367 / 1015M2M
Q2 20246815M16.5%23 / 2212 / 255M7M
Q1 20247017M18.8%17 / 1618 / 52M2M
Q4 20235817M18.6%5 / 1612 / 41M1M
Q3 20235717M18.5%7 / 1817 / 93M2M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

122 funds held VSTM in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of VSTMValue% of fundAs of
State Street(R) SPDR(R) S&P(R) Biotech ETF3,389,1133.74%$12.95M0.12%Jun 30, 2026
Vanguard Total Stock Market Index Fund2,811,9483.10%$10.74M0.00%Jun 30, 2026
iShares Russell 2000 ETF2,066,2042.28%$7.89M0.01%Jun 30, 2026
Vanguard Explorer Fund1,397,1721.54%$8.10M0.04%Jul 31, 2026
Vanguard Extended Market Index Fund960,5981.06%$3.67M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund872,7840.96%$5.06M0.01%Jul 31, 2026
iShares Russell 2000 Growth ETF750,1350.83%$2.87M0.02%Jun 30, 2026
BlackRock Advantage Small Cap Core Fund701,3370.77%$3.04M0.06%May 29, 2026
Fidelity Enhanced Small Cap Core ETF575,8990.64%$2.20M0.04%Jun 30, 2026
Vanguard Strategic Small-Cap Equity Fund536,6510.59%$2.05M0.07%Jun 30, 2026
Franklin Biotechnology Discovery Fund401,7440.44%$2.33M0.20%Jul 31, 2026
Fidelity Extended Market Index Fund378,5890.42%$1.64M0.00%May 31, 2026
Vanguard Russell 2000 Index Fund343,5610.38%$1.49M0.01%May 31, 2026
Virtus Biotech Etf331,0130.37%$1.92M1.95%Jul 31, 2026
Small Company Growth Portfolio330,4090.36%$1.26M0.07%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Dan PatersonPresident and CEO, Director844,5420.93%Nov 5, 2026
Michael KauffmanPresident of Development, Director8,6660.01%Jan 8, 2026
Daniel CalkinsChief Financial Officer123,7810.14%Oct 2, 2026
Matthew RosChief Operating Officer50,0000.06%Apr 3, 2025
Michael P. BaileyDirector108,0000.12%May 27, 2026
Michelle RobertsonDirector52,6660.06%May 26, 2026
Paul A. BunnDirector44,3330.05%May 26, 2026
Karin Anna TollefsonDirector52,6660.06%May 26, 2026
Eric K. RowinskyDirector54,6660.06%May 26, 2026
John JohnsonDirector52,6660.06%May 26, 2026
Brian M. StuglikDirector137,1470.15%May 26, 2026
Anil KapurDirector52,6660.06%May 26, 2026
Robert E. GagnonDirector41,6780.05%Dec 18, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Dan Paterson
President and CEO, Director
Nov 3, 2026Sale(10b5-1 plan)−1,299$9.60$12.47K651,413
Dan Paterson
President and CEO, Director
Oct 1, 2026Sale(10b5-1 plan)−44,121$8.00$352.97K652,712
Daniel Calkins
Chief Financial Officer
Oct 1, 2026Sale(10b5-1 plan)−2,566$8.00$20.53K123,781
Dan Paterson
President and CEO, Director
Sep 30, 2026Award−106,893––696,833
Daniel Calkins
Chief Financial Officer
Sep 30, 2026Award−8,333––126,347
Daniel Calkins
Chief Financial Officer
Sep 21, 2026Sale(10b5-1 plan)−55$7.70$424118,014
Dan Paterson
President and CEO, Director
Aug 3, 2026Sale(10b5-1 plan)−1,302$5.81$7.56K589,940
Dan Paterson
President and CEO, Director
Jun 22, 2026Sale(10b5-1 plan)−20,871$4.18$87.24K591,242
Daniel Calkins
Chief Financial Officer
Jun 22, 2026Sale(10b5-1 plan)−57$4.13$235117,238
Daniel Calkins
Chief Financial Officer
Jun 22, 2026Sale(10b5-1 plan)−4,032$4.18$16.85K117,295
Michael P. Bailey
Director
May 21, 2026Award+108,000––108,000
Paul A. Bunn
Director
May 21, 2026Award+36,000––44,333
Karin Anna Tollefson
Director
May 21, 2026Award+36,000––52,666
Anil Kapur
Director
May 21, 2026Award+36,000––52,666
Eric K. Rowinsky
Director
May 21, 2026Award+36,000––52,666
John Johnson
Director
May 21, 2026Award+36,000––52,666
Michelle Robertson
Director
May 21, 2026Award+36,000––52,666
Brian M. Stuglik
Director
May 21, 2026Award+36,000––137,147
Dan Paterson
President and CEO, Director
May 4, 2026Sale(10b5-1 plan)−806$5.82$4.69K612,113
Daniel Calkins
Chief Financial Officer
Mar 20, 2026Award−57$5.74$327121,327
Dan Paterson
President and CEO, Director
Feb 4, 2026Sale(10b5-1 plan)−970$6.69$6.49K612,919
Dan Paterson
President and CEO, Director
Jan 21, 2026Award+213,785––613,889
Daniel Calkins
Chief Financial Officer
Jan 21, 2026Award+16,665––121,384
Daniel Calkins
Chief Financial Officer
Jan 12, 2026Sale(10b5-1 plan)−5,039$7.16$36.08K104,719
Dan Paterson
President and CEO, Director
Jan 12, 2026Sale(10b5-1 plan)−10,321$7.16$73.90K400,104
Daniel Calkins
Chief Financial Officer
Dec 24, 2025Sale(10b5-1 plan)−80$7.86$629109,758
Brian M. Stuglik
Director
Dec 16, 2025Sale(10b5-1 plan)−592$9.14$5.41K101,147
Dan Paterson
President and CEO, Director
Dec 16, 2025Sale(10b5-1 plan)−393$9.14$3.59K410,425
Robert E. Gagnon
Director
Dec 16, 2025Sale(10b5-1 plan)−283$9.14$2.59K41,678
Dan Paterson
President and CEO, Director
Dec 11, 2025Sale(10b5-1 plan)−2,000$10.00$20.00K410,818
Dan Paterson
President and CEO, Director
Dec 10, 2025Sale(10b5-1 plan)−2,000$10.07$20.14K412,818
Dan Paterson
President and CEO, Director
Dec 9, 2025Sale(10b5-1 plan)−2,000$10.25$20.50K414,818
Dan Paterson
President and CEO, Director
Dec 8, 2025Sale(10b5-1 plan)−2,000$10.50$21.00K416,818
Dan Paterson
President and CEO, Director
Dec 5, 2025Sale(10b5-1 plan)−2,000$10.61$21.22K418,818
Dan Paterson
President and CEO, Director
Dec 4, 2025Sale(10b5-1 plan)−2,000$10.00$20.00K420,818
Dan Paterson
President and CEO, Director
Dec 3, 2025Sale(10b5-1 plan)−2,000$10.00$20.00K422,818
Dan Paterson
President and CEO, Director
Dec 2, 2025Sale(10b5-1 plan)−2,000$10.32$20.64K424,818
Dan Paterson
President and CEO, Director
Dec 1, 2025Sale(10b5-1 plan)−2,000$10.39$20.78K426,818
Dan Paterson
President and CEO, Director
Nov 28, 2025Sale(10b5-1 plan)−2,000$10.79$21.58K428,818
Dan Paterson
President and CEO, Director
Nov 26, 2025Sale(10b5-1 plan)−2,000$10.32$20.64K430,818
Dan Paterson
President and CEO, Director
Nov 25, 2025Sale(10b5-1 plan)−2,000$10.00$20.00K432,818
Dan Paterson
President and CEO, Director
Nov 24, 2025Sale(10b5-1 plan)−2,000$10.00$20.00K434,818
Dan Paterson
President and CEO, Director
Nov 21, 2025Sale(10b5-1 plan)−2,000$10.00$20.00K436,818
Michael Kauffman
Director
Nov 21, 2025Sale(10b5-1 plan)−8,550$10.00$85.50K8,666
Paul A. Bunn
Director
Nov 21, 2025Option exercise+6,250$3.27$20.44K8,333
Paul A. Bunn
Director
Nov 21, 2025Sale(10b5-1 plan)−6,250$10.00$62.50K2,083
Dan Paterson
President and CEO, Director
Nov 3, 2025Sale(10b5-1 plan)−2,000$10.00$20.00K438,818
Dan Paterson
President and CEO, Director
Nov 3, 2025Sale(10b5-1 plan)−1,299$9.35$12.15K440,818
Paul A. Bunn
Director
Oct 9, 2025Sale(10b5-1 plan)−8,333$9.06$75.50K8,333
Daniel Calkins
Chief Financial Officer
Sep 24, 2025Sale(10b5-1 plan)−25$9.23$231109,838
Daniel Calkins
Chief Financial Officer
Sep 22, 2025Sale(10b5-1 plan)−57$9.08$518109,863
Dan Paterson
President and CEO, Director
Sep 16, 2025Sale(10b5-1 plan)−390$9.99$3.90K442,117
Brian M. Stuglik
Director
Sep 16, 2025Sale(10b5-1 plan)−587$9.99$5.86K101,739
Robert E. Gagnon
Director
Sep 16, 2025Sale(10b5-1 plan)−281$9.99$2.81K41,961
Dan Paterson
President and CEO, Director
Aug 6, 2025Sale(10b5-1 plan)−1,332$5.81$7.74K442,507
Daniel Calkins
Chief Financial Officer
Jun 23, 2025Sale(10b5-1 plan)−25$4.71$118109,920
Dan Paterson
President and CEO, Director
Jun 20, 2025Sale(10b5-1 plan)−17,808$5.13$91.36K443,839
Daniel Calkins
Chief Financial Officer
Jun 20, 2025Sale(10b5-1 plan)−4,110$5.13$21.08K109,945
Dan Paterson
President and CEO, Director
Jun 16, 2025Sale−335$5.65$1.89K461,647
Brian M. Stuglik
Director
Jun 16, 2025Sale−594$5.65$3.36K102,326

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
22.11%
20M shares short
Days to cover
5.2
At 4M shares a day
Change since last report
+14.3%
From 17M shares
Short volume, 20 days
48.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Verastem's stock actually held short. Settlement fails (shares not delivered on time) peaked at 216,889 shares on Oct 8, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Dan Paterson
Officer, Director
Oct 1, 202644,121$353.05KOct 1, 2026Vesting of restricted stock unit award
Robert E. Gagnon
Director
Jul 23, 202631,924$188.03KJul 23, 2026Vested Restricted Stock Units
Robert E. Gagnon
Director
Jun 25, 202621,492$90.48KJun 25, 2026Vested Restricted Stock Units
Dan Paterson
Officer, Director
Jun 22, 202620,871$87.24KJun 22, 2026Vesting of restricted stock unit award
Robert E. Gagnon
Director
May 27, 202620,103$87.65KMay 27, 2026Vested Restricted Stock Units
Dan Paterson
Officer
Jan 14, 20265,039$36.07KJan 12, 2026Vesting of restricted stock unit award
Dan Paterson
Officer, Director
Jan 14, 202610,321$73.85KJan 12, 2026Vesting of restricted stock unit award
Dan Paterson
Officer
Dec 10, 202511,790$117.90KDec 5, 2025Acquired as compensation - RSU
Dan Paterson
Officer
Dec 9, 20257,790$80.00KDec 9, 2025Acquired as compensation
Paul A. Bunn
Board Member
Nov 21, 20256,250$61.31KNov 21, 2025Stock Option Grant
Michael Kauffman
Board Member
Nov 21, 20258,550$83.88KNov 21, 2025Restricted Stock Grant
Paul A. Bunn
Board Member
Oct 9, 20258,333$74.50KOct 9, 2025Restricted Stock Grant
Dan Paterson
Officer, Director
Sep 4, 202531,790$310.43KSep 17, 2025Acquired as Compensation - RSUs
Dan Paterson
Officer, Director
Jun 20, 202517,808$91.33KJun 20, 2025Vesting of restricted stock unit award
Dan Paterson
Officer, Director
May 20, 202558,677$477.04KMay 20, 2025Vesting of restricted stock unit award

See a number that looks wrong?